286 related articles for article (PubMed ID: 6872314)
1. Lymphocyte counts and functions in arterial and venous splenic blood of patients with Hodgkin's disease. Evidence for elimination of spontaneously DNA synthesizing cells in the spleen.
Björkholm M; Holm G; Askergren J; Mellstedt H
Clin Exp Immunol; 1983 Jun; 52(3):485-92. PubMed ID: 6872314
[TBL] [Abstract][Full Text] [Related]
2. Impaired lymphocyte transformation in Hodgkin's disease. Evidence for depletion of circulating t-lymphocytes.
Matchett KM; Huang AT; Kremer WB
J Clin Invest; 1973 Aug; 52(8):1908-17. PubMed ID: 4541673
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors in Hodgkin's disease. II. Role of the lymphocyte defect.
Björkholm M; Holm G; Mellstedt H; Johansson B; Killander D; Sunblad R; Söderberg G
Scand J Haematol; 1978 Apr; 20(4):306-18. PubMed ID: 653310
[TBL] [Abstract][Full Text] [Related]
4. Persisting lymphocyte deficiences during remission in Hodgkin's disease.
Björkholm M; Holm G; Mellstedt H
Clin Exp Immunol; 1977 Jun; 28(3):389-93. PubMed ID: 302164
[TBL] [Abstract][Full Text] [Related]
5. [Proportions and absolute count of T- and B-lymphocytes in peripheral blood and their blastic transformation induced by mitogens in splenectomized and non-splenectomized patients with Hodgkin's disease].
Pluzańska A
Acta Haematol Pol; 1978; 9(1):37-44. PubMed ID: 307325
[TBL] [Abstract][Full Text] [Related]
6. In vitro responses of peripheral blood and spleen lymphoid cells to mitogens and antigens in childhood Hodgkin's disease.
Tan CT; de Sousa M; Tan R; Hansen JA; Good RA
Cancer Res; 1978 Apr; 38(4):886-93. PubMed ID: 346206
[TBL] [Abstract][Full Text] [Related]
7. Immune status of untreated patients with Hodgkin's disease and prognosis.
Björkholm M; Wedelin C; Holm G; Ogenstad S; Johansson B; Mellstedt H
Cancer Treat Rep; 1982 Apr; 66(4):701-9. PubMed ID: 7074640
[TBL] [Abstract][Full Text] [Related]
8. Blood lymphocyte functions in relation to splenic weight and tumor involvement in untreated Hodgkin's disease.
Björkholm M; Askergren J; Wedelin C; Holm G; Mellstedt H
Scand J Haematol; 1980 Jul; 25(1):51-7. PubMed ID: 6969422
[TBL] [Abstract][Full Text] [Related]
9. Spleen lymphocyte populations in patients with Hodgkin's disease--properties of cells with different densities.
Rocha B; Ferreira AA; Munn G; de Sousa M; Freitas AA
Clin Exp Immunol; 1982 May; 48(2):300-6. PubMed ID: 7105487
[TBL] [Abstract][Full Text] [Related]
10. Lymphocytotoxic serum factors and lymphocyte functions in untreated Hodgkin's disease.
Björkholm M; Wedelin C; Holm G; Ericsson H; Nilsson P; Mellstedt H
Cancer; 1982 Nov; 50(10):2044-8. PubMed ID: 7127249
[TBL] [Abstract][Full Text] [Related]
11. Ecotaxis: the principle and its application to the study of Hodgkin's disease.
Sousa MD; Yang M; Lopes-Corrales E; Tan C; Hansen JA; Dupont B; Good RA
Clin Exp Immunol; 1977 Jan; 27(1):143-51. PubMed ID: 300302
[TBL] [Abstract][Full Text] [Related]
12. [Role of splenectomy in impairing lymphocyte elimination in patients with lymphogranulomatosis].
Kuz'mina EG; Bogatyreva TI; Baĭsogolov GD; Iarilin AA
Vopr Onkol; 1986; 32(8):65-8. PubMed ID: 3765511
[TBL] [Abstract][Full Text] [Related]
13. SPLEEN/PATHOL.
Bukowski RM; Noguchi S; Hewlett JS; Deodhar S
Am J Clin Pathol; 1976 Jan; 65(1):30-9. PubMed ID: 1082240
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxic activity of lymphocytes from patients with Hodgkin's disease.
Holm G; Björkholm M; Mellstedt H; Johansson B
Clin Exp Immunol; 1975 Sep; 21(3):376-83. PubMed ID: 1081933
[TBL] [Abstract][Full Text] [Related]
15. [Hodgkin's disease. T lymphocyte defect in patients in complete remission (author's transl)].
Lang JM; Bigel P; Oberling F; Mayer S
Pathol Biol (Paris); 1978; 26(3-4):159-62. PubMed ID: 355984
[TBL] [Abstract][Full Text] [Related]
16. [Hodgkin's disease. T lymphocyte defect in patients in complete remission (author's transl)].
Lang JM; Bigel P; Oberling F; Mayer S
Sem Hop; 1978 Nov 8-15; 54(37-40):1155-8. PubMed ID: 217096
[TBL] [Abstract][Full Text] [Related]
17. A micro-method for PHA-induced stimulation of human lymphocytes. II. communication: effect of splenectomy on the inhibitory activity of serum in patients with Hodgkin's disease.
Pappas A; Pees H; Girmann G
Z Immunitatsforsch Immunobiol; 1977 Apr; 153(1):1-10. PubMed ID: 868205
[TBL] [Abstract][Full Text] [Related]
18. Splenic T and B lymphocytes and their mitogenic response in untreated Hodgkin's disease.
Han T; Minowada J; Subramanian V; Barcos M; Kim U
Cancer; 1980 Feb; 45(4):767-74. PubMed ID: 6965606
[TBL] [Abstract][Full Text] [Related]
19. Serum zinc levels, lymphocyte counts and functions in pediatric Hodgkin's disease.
Babacan E; Cavdar AO; Arcasoy A
Boll Ist Sieroter Milan; 1977 Jul; 56(3):228-34. PubMed ID: 901636
[TBL] [Abstract][Full Text] [Related]
20. Spontaneous lymphocyte proliferation and depressed cellular immunity in Hodgkin's disease.
Shiftan TA; Caviles AP; Mendelsohn J
Clin Exp Immunol; 1978 Apr; 32(1):144-52. PubMed ID: 668190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]